Vicky Han | Senior Director, Regulatory Policy Group Lead for Asia Pacific
Janssen Pharmaceuticals | United States

Vicky Han, Senior Director, Regulatory Policy Group Lead for Asia Pacific, Janssen Pharmaceuticals

Vicky Han, Senior Director, Group Lead for Regulatory Policy in Asia Pacific at Johnson & Johnson Pharmaceuticals, is currently in charge of Asia Pacific regulatory policy, in particular focusing on China and Japan, while engaging with external stakeholders for improving the regulatory environment.

Vicky has dedicated 18 years of her career to GSK with several positions in different countries: 12 years in GSK China for leading pharmaceuticals and vaccines regulatory affairs. She moved to GSK vaccines headquarters in Belgium in 2008, where she led a team responsible for worldwide cross-product regulatory affairs, and dealt directly with EMA for vaccines registration. In 2011, she relocated to GSK pharmaceuticals headquarters in London as the Senior Director & China expert in GRA, responsible for overseeing regulatory strategies in China. Vicky came back to Asia in February 2014, with a position heading Asia regulatory affairs in Hospira (a Pfizer company now) in Singapore for 2 years. 

Vicky has extensive regulatory experiences throughout chemical & biological products, vaccines, Biosimilars and generics across different countries in Asia Pacific and Europe.

Appearances:



Phar-East Day Two @ 14:05

Panel discussion: Using Real World Evidence (RWE) to support the rational use of medicine in Asia

  • Practicality issues in using RWE in Asia
  • Challenges and opportunities of regulatory innovation for SME pharma companies
  • RWE on emerging therapeutics: Key challenges and opportunities

back to speakers